CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 2
Operating expenses:
Research and development	388	185	814	531
General and administrative	564	854	1,150	1,603
Total operating expenses	952	1,039	1,964	2,134
Loss from operations	(952)	(1,039)	(1,964)	(2,132)
Other income (expense):
Change in fair value of warrant liability	0	(31)	0	(31)
Other income (expense), net	0	19	6	39
Other income (expense), net	0	(12)	6	8
Net loss	$ (952)	$ (1,051)	$ (1,958)	$ (2,124)
Earnings per share, Basic	$ (0.41)	$ (0.63)	$ (0.85)	$ (1.3)
Earnings per share, Diluted	$ (0.41)	$ (0.63)	$ (0.85)	$ (1.3)
Weighted average common shares outstanding, basic	2,431,695	1,676,345	2,397,404	1,639,123
Weighted average common shares outstanding, diluted	2,431,695	1,676,345	2,397,404	1,639,123